Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
about
Current trends and intricacies in the management of HIV-associated pulmonary tuberculosisCD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profilesManagement of rheumatoid arthritis in People's Republic of China - focus on tocilizumab and patient considerationsRheumatoid arthritis: refractory to infliximab, a tumor necrosis factor inhibitor.The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity.Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndromeInterleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts.Assessment of the link between in utero exposure to 2-aminoanthracene (2AA) and type-1 diabetes (T1D).Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouse.Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells.The ubiquitous interleukin-6: a time for reappraisal.Astilbin from Smilax glabra Roxb. Attenuates Inflammatory Responses in Complete Freund's Adjuvant-Induced Arthritis Rats.Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity.Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid Arthritis
P2860
Q28069032-3DA987A9-27AA-4D32-A40B-AA469DD6D5D0Q33996745-1BDC250D-AA3A-4A6A-B041-23F06980B0B0Q35618458-7B64ABB3-A40F-446F-BA7D-A53F2F5AA5EEQ35757007-C592370B-F15A-4AF8-89A4-4C95B82D9F5DQ35816023-C23E0AC9-974B-41DA-96BF-F880C7AFBB85Q36238260-EF9E5F31-392D-4917-BBEC-9112A426BFE3Q36868230-C0E883FF-0628-4E4D-A6A4-6A0CA21152C3Q37611066-8D4FBC93-B776-4A42-A027-2E2B95B7630AQ39205496-3C681C59-4391-41D3-9467-FA2FA47F6A2FQ41615232-0F3915B4-15CE-4353-AC9B-02C4BB9007EFQ42407082-85C9CCFA-D58F-4A8B-A205-7B40D8873195Q43409157-BF4B58AB-40AF-4DD9-A839-1108A41C109BQ48509546-FF06DD2C-AA6E-4EB2-94BE-48F25B6A3C26Q58701267-CD9F82D0-2B05-4B7D-8D44-E470EAA8C8E2
P2860
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
@en
type
label
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
@en
prefLabel
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
@en
P2860
P356
P1476
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
@en
P2093
Arthur Kavanaugh
Stephanie Hennigan
P2860
P304
P356
10.2147/TCRM.S3470
P577
2008-08-01T00:00:00Z